BEONE MEDICINES LTD. Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
BEONE MEDICINES LTD. (ONC) reported Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest of -$533.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments · last filed 2025-02-27
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2023-12-31 was -$350.77M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2023-09-30 was $229.34M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2023-06-30 was -$367.46M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for the quarter ending 2023-03-31 was -$336.94M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2024 was -$533.00M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2023 was -$825.84M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2022 was -$1.96B.
- BEONE MEDICINES LTD. income (loss) from continuing operations before equity method investments, income taxes, noncontrolling interest for fiscal 2021 was -$1.44B.
| Period end | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$533.00M 10-K · filed 2025-02-27 | |||
| 2023-12-31 | -$350.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$121.43M derived: sum of 2 quarters · filed 2025-02-27 | -$488.90M derived: sum of 3 quarters · filed 2025-02-27 | -$825.84M 10-K · filed 2025-02-27 |
| 2023-09-30 | $229.34M 10-Q · filed 2023-11-09 | -$138.13M derived: sum of 2 quarters · filed 2023-11-09 | -$475.06M 10-Q · filed 2023-11-09 | -$906.03M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$367.46M 10-Q · filed 2023-08-02 | -$704.40M 10-Q · filed 2023-08-02 | -$1.14B derived: sum of 3 quarters · filed 2025-02-27 | -$1.69B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$336.94M 10-Q · filed 2023-05-04 | -$767.90M derived: sum of 2 quarters · filed 2025-02-27 | -$1.32B derived: sum of 3 quarters · filed 2025-02-27 | -$1.88B derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$430.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$982.20M derived: sum of 2 quarters · filed 2025-02-27 | -$1.54B derived: sum of 3 quarters · filed 2025-02-27 | -$1.96B 10-K · filed 2025-02-27 |
| 2022-09-30 | -$551.24M 10-Q · filed 2023-11-09 | -$1.11B derived: sum of 2 quarters · filed 2023-11-09 | -$1.53B 10-Q · filed 2023-11-09 | -$2.12B derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$557.59M 10-Q · filed 2023-08-02 | -$978.83M 10-Q · filed 2023-08-02 | -$1.57B derived: sum of 3 quarters · filed 2024-02-26 | -$2.00B derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$421.25M 10-Q · filed 2023-05-04 | -$1.01B derived: sum of 2 quarters · filed 2024-02-26 | -$1.44B derived: sum of 3 quarters · filed 2024-02-26 | -$1.92B derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$586.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$1.02B derived: sum of 2 quarters · filed 2024-02-26 | -$1.50B derived: sum of 3 quarters · filed 2024-02-26 | -$1.44B 10-K · filed 2024-02-26 |
| 2021-09-30 | -$433.08M 10-Q · filed 2022-11-09 | -$913.65M derived: sum of 2 quarters · filed 2022-11-09 | -$851.78M 10-Q · filed 2022-11-09 | -$1.33B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$480.57M 10-Q · filed 2022-08-08 | -$418.71M 10-Q · filed 2022-08-08 | -$900.68M derived: sum of 3 quarters · filed 2023-02-27 | -$1.34B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $61.87M 10-Q · filed 2022-05-09 | -$420.11M derived: sum of 2 quarters · filed 2023-02-27 | -$855.15M derived: sum of 3 quarters · filed 2023-02-27 | -$1.19B derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$481.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$917.02M derived: sum of 2 quarters · filed 2023-02-27 | -$1.25B derived: sum of 3 quarters · filed 2023-02-27 | -$1.62B 10-K · filed 2023-02-27 |
| 2020-09-30 | -$435.04M 10-Q · filed 2021-11-04 | -$772.83M derived: sum of 2 quarters · filed 2021-11-04 | -$1.14B 10-Q · filed 2021-11-04 | -$1.52B derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$337.79M 10-Q · filed 2021-08-05 | -$701.18M 10-Q · filed 2021-08-05 | -$1.08B derived: sum of 3 quarters · filed 2022-02-28 | -$1.39B derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$363.38M 10-Q · filed 2021-05-06 | -$743.72M derived: sum of 2 quarters · filed 2022-02-28 | -$1.06B derived: sum of 3 quarters · filed 2022-02-28 | -$1.14B derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$380.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$692.21M derived: sum of 2 quarters · filed 2022-02-28 | -$776.04M derived: sum of 3 quarters · filed 2022-02-28 | -$943.59M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$311.88M 10-Q · filed 2020-11-05 | -$395.70M derived: sum of 2 quarters · filed 2020-11-05 | -$563.25M 10-Q · filed 2020-11-05 | -$838.51M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$83.83M 10-Q · filed 2020-08-06 | -$251.38M 10-Q · filed 2020-08-06 | -$526.63M derived: sum of 3 quarters · filed 2021-02-25 | -$671.59M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$167.55M 10-Q · filed 2020-05-11 | -$442.80M derived: sum of 2 quarters · filed 2021-02-25 | -$587.77M derived: sum of 3 quarters · filed 2021-02-25 | -$748.85M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$275.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$420.22M derived: sum of 2 quarters · filed 2021-02-25 | -$581.30M derived: sum of 3 quarters · filed 2021-02-25 | -$689.83M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$144.96M 10-Q · filed 2019-11-12 | -$306.05M derived: sum of 2 quarters · filed 2019-11-12 | -$414.57M 10-Q · filed 2019-11-12 | -$508.94M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$161.08M 10-Q · filed 2019-08-08 | -$269.61M 10-Q · filed 2019-08-08 | -$363.98M derived: sum of 3 quarters · filed 2020-03-02 | -$249.75M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$108.53M 10-Q · filed 2019-05-09 | -$202.89M derived: sum of 2 quarters · filed 2020-03-02 | -$88.67M derived: sum of 3 quarters · filed 2020-03-02 | -$149.15M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$94.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $19.86M derived: sum of 2 quarters · filed 2020-03-02 | -$40.62M derived: sum of 3 quarters · filed 2020-03-02 | -$91.06M 10-K · filed 2020-03-02 |
| 2017-09-30 | $114.22M 10-Q · filed 2018-11-08 | $53.74M derived: sum of 2 quarters · filed 2018-11-08 | $3.30M 10-Q · filed 2018-11-08 | -$34.55M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$60.48M 10-Q · filed 2018-08-09 | -$110.92M 10-Q · filed 2018-08-09 | -$148.77M derived: sum of 3 quarters · filed 2019-02-28 | -$184.14M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$50.44M 10-Q · filed 2018-05-09 | -$88.29M derived: sum of 2 quarters · filed 2019-02-28 | -$123.66M derived: sum of 3 quarters · filed 2019-02-28 | -$147.65M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$37.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$73.22M derived: sum of 2 quarters · filed 2019-02-28 | -$97.21M derived: sum of 3 quarters · filed 2019-02-28 | -$119.16M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$35.37M 10-Q · filed 2016-11-10 | -$59.36M derived: sum of 2 quarters · filed 2016-11-10 | -$81.31M 10-Q · filed 2016-11-10 | -$108.56M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$23.99M 10-Q · filed 2016-08-10 | -$45.95M 10-Q · filed 2016-08-10 | -$73.20M derived: sum of 3 quarters · filed 2018-02-28 | -$87.19M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$21.96M 10-Q · filed 2016-05-12 | -$49.21M derived: sum of 2 quarters · filed 2018-02-28 | -$63.21M derived: sum of 3 quarters · filed 2018-02-28 | -$68.85M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | -$27.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$41.25M derived: sum of 2 quarters · filed 2018-02-28 | -$46.89M derived: sum of 3 quarters · filed 2018-02-28 | -$57.10M 10-K · filed 2018-02-28 |
| 2015-09-30 | -$14.00M 10-Q · filed 2016-11-10 | -$19.64M derived: sum of 2 quarters · filed 2016-11-10 | -$29.85M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | -$5.64M 10-Q · filed 2016-08-10 | -$15.85M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$10.21M 10-Q · filed 2016-05-12 |